PIRAMAL PHARMA
|
PIRAMAL PHARMA Last 5 Year Income Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹10,518 Cr | ₹10,620 Cr | ₹9,421 Cr | ₹8,107 Cr | ₹7,306 Cr |
| Sales | ₹9,475 Cr | ₹9,516 Cr | ₹8,316 Cr | ₹7,014 Cr | ₹6,324 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | ₹933 Cr | ₹1,014 Cr | ₹1,040 Cr | ₹1,043 Cr | ₹854 Cr |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹110 Cr | ₹90 Cr | ₹65 Cr | ₹49 Cr | ₹128 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹8,869 Cr | ₹9,151 Cr | ₹8,171 Cr | ₹7,082 Cr | ₹6,559 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-188 Cr | ₹-241 Cr | ₹-199 Cr | ₹69 Cr | ₹55 Cr |
| Raw Material Consumed | ₹3,426 Cr | ₹3,473 Cr | ₹3,153 Cr | ₹2,635 Cr | ₹2,396 Cr |
| Opening Raw Materials | ₹936 Cr | ₹1,022 Cr | ₹728 Cr | ₹599 Cr | ₹449 Cr |
| Purchases Raw Materials | ₹2,518 Cr | ₹1,970 Cr | ₹2,270 Cr | ₹1,812 Cr | ₹1,717 Cr |
| Closing Raw Materials | ₹1,458 Cr | ₹936 Cr | ₹1,022 Cr | ₹728 Cr | ₹599 Cr |
| Other Direct Purchases / Brought in cost | ₹1,431 Cr | ₹1,417 Cr | ₹1,176 Cr | ₹952 Cr | ₹829 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹260 Cr | ₹267 Cr | ₹242 Cr | ₹208 Cr | ₹164 Cr |
| Electricity & Power | ₹260 Cr | ₹267 Cr | ₹242 Cr | ₹208 Cr | ₹164 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹2,416 Cr | ₹2,307 Cr | ₹2,030 Cr | ₹1,896 Cr | ₹1,589 Cr |
| Salaries, Wages & Bonus | ₹2,034 Cr | ₹1,957 Cr | ₹1,724 Cr | ₹1,642 Cr | ₹1,368 Cr |
| Contributions to EPF & Pension Funds | ₹173 Cr | ₹148 Cr | ₹130 Cr | ₹115 Cr | ₹102 Cr |
| Workmen and Staff Welfare Expenses | ₹157 Cr | ₹148 Cr | ₹143 Cr | ₹136 Cr | ₹115 Cr |
| Other Employees Cost | ₹52 Cr | ₹54 Cr | ₹33 Cr | ₹3.64 Cr | ₹3.81 Cr |
| Other Manufacturing Expenses | ₹808 Cr | ₹774 Cr | ₹732 Cr | ₹674 Cr | ₹589 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | ₹13 Cr | ₹13 Cr | ₹19 Cr | ₹23 Cr | ₹12 Cr |
| Repairs and Maintenance | ₹339 Cr | ₹323 Cr | ₹308 Cr | ₹268 Cr | ₹220 Cr |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | ₹456 Cr | ₹438 Cr | ₹405 Cr | ₹383 Cr | ₹357 Cr |
| General and Administration Expenses | ₹593 Cr | ₹563 Cr | ₹542 Cr | ₹473 Cr | ₹428 Cr |
| Rent , Rates & Taxes | ₹132 Cr | ₹127 Cr | ₹121 Cr | ₹89 Cr | ₹102 Cr |
| Insurance | ₹56 Cr | ₹49 Cr | ₹46 Cr | ₹44 Cr | ₹43 Cr |
| Printing and stationery | ₹69 Cr | ₹56 Cr | ₹42 Cr | ₹43 Cr | ₹45 Cr |
| Professional and legal fees | ₹194 Cr | ₹195 Cr | ₹202 Cr | ₹174 Cr | ₹136 Cr |
| Traveling and conveyance | ₹95 Cr | ₹97 Cr | ₹77 Cr | ₹66 Cr | ₹35 Cr |
| Other Administration | ₹46 Cr | ₹38 Cr | ₹53 Cr | ₹57 Cr | ₹68 Cr |
| Selling and Distribution Expenses | ₹438 Cr | ₹398 Cr | ₹360 Cr | ₹373 Cr | ₹318 Cr |
| Advertisement & Sales Promotion | ₹200 Cr | ₹177 Cr | ₹142 Cr | ₹176 Cr | ₹151 Cr |
| Sales Commissions & Incentives | ₹5.95 Cr | ₹5.87 Cr | ₹7.70 Cr | ₹3.01 Cr | - |
| Freight and Forwarding | ₹183 Cr | ₹167 Cr | ₹154 Cr | ₹145 Cr | ₹133 Cr |
| Handling and Clearing Charges | ₹49 Cr | ₹49 Cr | ₹56 Cr | ₹49 Cr | ₹32 Cr |
| Other Selling Expenses | - | - | - | - | ₹1.18 Cr |
| Miscellaneous Expenses | ₹223 Cr | ₹192 Cr | ₹142 Cr | ₹126 Cr | ₹70 Cr |
| Bad debts /advances written off | ₹41 Cr | ₹27 Cr | ₹26 Cr | - | - |
| Provision for doubtful debts | ₹19 Cr | ₹27 Cr | ₹31 Cr | ₹42 Cr | ₹8.60 Cr |
| Losson disposal of fixed assets(net) | - | - | ₹0.46 Cr | ₹0.48 Cr | ₹0.54 Cr |
| Losson foreign exchange fluctuations | - | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹163 Cr | ₹138 Cr | ₹84 Cr | ₹84 Cr | ₹61 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹7,977 Cr | ₹7,733 Cr | ₹7,001 Cr | ₹6,453 Cr | ₹5,609 Cr |
| Operating Profit (Excl OI) | ₹892 Cr | ₹1,418 Cr | ₹1,171 Cr | ₹628 Cr | ₹950 Cr |
| Other Income | ₹242 Cr | ₹162 Cr | ₹201 Cr | ₹225 Cr | ₹276 Cr |
| Interest Received | ₹7.07 Cr | ₹11 Cr | ₹12 Cr | ₹1.64 Cr | ₹0.68 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | ₹6.92 Cr | ₹1.93 Cr | - | - | - |
| Profits on sale of Investments | ₹2.23 Cr | ₹1.44 Cr | ₹4.27 Cr | ₹1.58 Cr | ₹1.95 Cr |
| Provision Written Back | ₹85 Cr | ₹45 Cr | ₹73 Cr | ₹49 Cr | ₹60 Cr |
| Foreign Exchange Gains | ₹50 Cr | ₹38 Cr | ₹30 Cr | ₹111 Cr | ₹17 Cr |
| Others | ₹91 Cr | ₹65 Cr | ₹82 Cr | ₹62 Cr | ₹196 Cr |
| Operating Profit | ₹1,135 Cr | ₹1,580 Cr | ₹1,372 Cr | ₹853 Cr | ₹1,225 Cr |
| Interest | ₹341 Cr | ₹422 Cr | ₹448 Cr | ₹344 Cr | ₹198 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | - | - | - | - | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹2.45 Cr | ₹3.66 Cr | ₹1.54 Cr | ₹6.47 Cr | ₹9.47 Cr |
| Other Interest | ₹338 Cr | ₹418 Cr | ₹447 Cr | ₹338 Cr | ₹189 Cr |
| PBDT | ₹794 Cr | ₹1,158 Cr | ₹923 Cr | ₹509 Cr | ₹1,027 Cr |
| Depreciation | ₹831 Cr | ₹816 Cr | ₹741 Cr | ₹677 Cr | ₹586 Cr |
| Profit Before Taxation & Exceptional Items | ₹-37 Cr | ₹342 Cr | ₹183 Cr | ₹-168 Cr | ₹441 Cr |
| Exceptional Income / Expenses | ₹-196 Cr | - | ₹-63 Cr | ₹-6.96 Cr | ₹-15 Cr |
| Profit Before Tax | ₹-176 Cr | ₹415 Cr | ₹179 Cr | ₹-120 Cr | ₹485 Cr |
| Provision for Tax | ₹150 Cr | ₹324 Cr | ₹161 Cr | ₹66 Cr | ₹109 Cr |
| Current Income Tax | ₹162 Cr | ₹311 Cr | ₹190 Cr | ₹98 Cr | ₹191 Cr |
| Deferred Tax | ₹-12 Cr | ₹13 Cr | ₹-24 Cr | ₹-44 Cr | ₹-82 Cr |
| Other taxes | - | ₹-0.91 Cr | ₹-5.04 Cr | ₹12 Cr | - |
| Profit After Tax | ₹-326 Cr | ₹91 Cr | ₹18 Cr | ₹-186 Cr | ₹376 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | - | - | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹-326 Cr | ₹91 Cr | ₹18 Cr | ₹-186 Cr | ₹376 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹1,049 Cr | ₹971 Cr | ₹956 Cr | ₹1,159 Cr | ₹833 Cr |
| Appropriations | ₹723 Cr | ₹1,062 Cr | ₹974 Cr | ₹972 Cr | ₹1,209 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹31 Cr | ₹12 Cr | ₹3.56 Cr | ₹16 Cr | ₹50 Cr |
| Equity Dividend % | - | ₹1.40 | ₹1.10 | - | - |
| Earnings Per Share | ₹-2.46 | ₹0.69 | ₹0.13 | ₹-1.56 | ₹3.17 |
| Adjusted EPS | ₹-2.46 | ₹0.69 | ₹0.13 | ₹-1.53 | ₹3.10 |
Compare Income Statement of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹23,570.7 Cr | 1.3% | 11.6% | -14.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 1.3% |
11.6% |
-14.6% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses